Investor confidence in Ghana’s indigenous industrial capability has elevated considerably following giant stake acquisitions within the native inventory market.
Zagadat Capital GH. Ltd. has efficiently secured a considerable 17.31 per cent stake in Intravenous Infusions PLC, a number one native pharmaceutical producer listed on the Ghana Various Alternate (GAX) below the ticker image IIL.
The transaction was formally introduced by means of a big holding discover issued on Monday, Could 18, 2026. Zagadat Capital, the funding agency celebrating Nigerian musician and company entrepreneur Oluwatosin “Mr. Straightforward” Ajibade as chief funding officer, has acquired a complete of 47,514,775 shares, regulatory disclosures have revealed.
This block represents nearly all of the pharmaceutical firm’s whole excellent share capital base of 274.41 million shares.
This acquisition was all completed by means of a sequence of open market purchases on the ground of GAX. To facilitate the transaction course of, the funding agency retained the technical companies of Laurus Africa Securities, which acted because the approved buying and selling member to dealer the multi-million share transaction.
The transfer comes on the heels of the publication of Intravenous Infusions PLC’s 2025 Annual Report, which highlights the corporate’s operational resilience as a completely Ghanaian entity devoted to the high-volume manufacturing of vital intravenous fluids, life-saving saline options, and quite a lot of pharmaceutical formulations.
Following the profitable transaction, Zagadat Capital’s administration defined that the shares have been accrued as a part of a deliberate long-term funding technique to broaden the home medical provide chain.
The corporate mentioned the capital injection displays its agency perception within the business viability of native pharmaceutical manufacturing, including that it views Intravenous Infusions PLC as an organization of nice structural significance to the West African healthcare ecosystem.
To forestall public misunderstandings and hypothesis relating to hostile adjustments in company governance, Zagadat Capital has clarified its structural boundaries. The corporate mentioned the inventory buy was not supposed to trigger a company takeover or destabilize the corporate’s present administration.
As an alternative, the corporate emphasised that its entry into the share register is geared toward sustaining the producer’s long-term progress and constructing a powerful, collaborative partnership that may maximize worth for all present stakeholders.
This formal notification has been filed in strict accordance with the transparency provisions of the Securities Business Act 2016 (Act 929) and the statutory laws of the Ghana Inventory Alternate. Beneath these legal guidelines, traders are legally required to file disclosures the second their shareholdings exceed key institutional thresholds for listed corporations.
